- NORTH AMERICA EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Canadian Orebodies Assay update
Canadian Orebodies Inc. (TSX VENTURE:CO) reported assay results from the channel sampling program which has demonstrated rich, wide spread zones of lithium/rare metals on Orebodies Falcon Property, located approximately 60km NE of Armstrong, Ontario.
Canadian Orebodies Inc. (TSX VENTURE:CO) reported assay results from the channel sampling program which has demonstrated rich, wide spread zones of lithium/rare metals on Orebodies Falcon Property, located approximately 60km NE of Armstrong, Ontario.
The press release is quoted as saying:
The Falcon Property consists of 60 claim units and is owned 100% by Orebodies (subject to a 2% NSR, 50% of which can be purchased by Orebodies for $1,000,000).
Click here to access the entire press release
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â